We are pleased to announce the 2nd Wellcome Trust Conference on Cancer Pharmacogenomics and Targeted Therapies. The conference will once again bring together leading scientists and clinician-scientists from academia and industry to focus on the key challenges in the design, development and clinical implementation of targeted cancer therapies.